Host by China Pharmaceutical Industry Association (CPIA) and BMAP, the leading life science events organizer, the 3rd World-China Super Generics Forum will gather 300+ leaders of R & D from leading pharmaceutical companies, to have a deep discussion on the challenges addressed above.
Tracking the latest policies, regulations and guidance of generic drug consistency evaluation, BE tests at home and abroad
Communicating case studies and experience of generic drug consistency evaluation in different dosage forms
Discussing dissolution experiments, IVIVC and BE tests design, to improve the pass rate of BE tests
Learning the latest dynamics of the application and development of class 2 and 505b2 new drug registration from leading enterprises
Exploring the differentiation strategy of generic drug development, innovative drug delivery systems and formulations, to break through chemical drug innovation